Live from the NIH registry
Studies recruiting near Antioch right now
Top 25 of 451 recruiting studies, sorted by proximity — each links to its official registry page
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Epic Care Cyberknife Center — Walnut Creek, California (15.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
UCSF Benioff Children's Hospital Oakland — Oakland, California (28.6 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Walnut Creek, California (15.5 mi)
· Sponsor: AstraZeneca
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Bass Medical Group ( Site 0123) — Walnut Creek, California (15.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Bay Area Retina Associates - Walnut Creek — Walnut Creek, California (15.5 mi)
· Sponsor: Boehringer Ingelheim
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Kaiser Permanente-Deer Valley Medical Center — Antioch, California (1.9 mi)
· Sponsor: SWOG Cancer Research Network
Alcohol-ROC-Training
Binge Drinking, Heavy Drinking
N/A
Interventional 177 participants sought
University of California, Berkeley — Berkeley, California (27.0 mi)
· Sponsor: Yale University
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
NorCal Endocrinology and Internal Medicine — San Ramon, California (16.9 mi)
· Sponsor: Novo Nordisk A/S
MMA Embolization for Refractory Chronic Migraine
Migraine Disorders
N/A
Interventional 70 participants sought
John Muir Physician Network Clin. Research Center — Walnut Creek, California (15.5 mi)
· Sponsor: Cerenovus, Part of DePuy Synthes Products, Inc.
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
BASS Medical Group - Lennon — Walnut Creek, California (15.5 mi)
· Sponsor: NRG Oncology
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Hereditary Angioedema, HAE
Phase 3
Interventional 90 participants sought
ADARx Clinical Site — Walnut Creek, California (15.5 mi)
· Sponsor: ADARx Pharmaceuticals, Inc.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Kaiser Permanente - Walnut Creek Medical Center — Walnut Creek, California (15.5 mi)
· Sponsor: American Society of Clinical Oncology
Stress Hydrocortisone In Pediatric Septic Shock
Septic Shock
Phase 3
Interventional 500 participants sought
UCSF Benioff Children's Hospital - Oakland — Oakland, California (28.6 mi)
· Sponsor: Jerry Zimmerman
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
Alta Bates Summit Medical Center ( Site 0004) — Berkeley, California (27.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Multicenter Multinational Observational Study of Children With Hypochondroplasia
Hypochondroplasia
N/A
Observational 400 participants sought
UCSF Benioff Children's Hospital — Oakland, California (28.6 mi)
· Sponsor: BioMarin Pharmaceutical
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Sunwise Clinical Research /ID# 270431 — Walnut Creek, California (15.5 mi)
· Sponsor: AbbVie
A Study of Dotinurad Versus Allopurinol in Participants With Gout
Gout
Phase 3
Interventional 500 participants sought
West Coast Research — Dublin, California (20.6 mi)
· Sponsor: Crystalys Therapeutics
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Kaiser Permanente - Walnut Creek ( Site 0078) — Walnut Creek, California (15.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Standard Versus High Dose ED-Initiated Buprenorphine Induction
Opioid Use Disorder
Phase 3
Interventional 360 participants sought
San Leandro Hospital — San Leandro, California (26.3 mi)
· Sponsor: Yale University
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Deer Valley Medical Center — Antioch, California (1.9 mi)
· Sponsor: NRG Oncology
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8
Phase 3
Interventional 228 participants sought
Kaiser Permanente-Walnut Creek — Walnut Creek, California (15.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
John Muir Physician Network Clinical Research Center — Concord, California (12.8 mi)
· Sponsor: Boehringer Ingelheim
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Diablo Clinical Research, Inc. — Walnut Creek, California (15.5 mi)
· Sponsor: Novo Nordisk A/S
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Kaiser Permanente-Walnut Creek — Walnut Creek, California (15.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Geographic Atrophy, Macular Degeneration
Phase 2
Interventional 274 participants sought
Bay Area Retina Associates — Walnut Creek, California (15.5 mi)
· Sponsor: Janssen Research & Development, LLC